UA103206C2 - Compounds that expand hematopoietic stem cells - Google Patents
Compounds that expand hematopoietic stem cellsInfo
- Publication number
- UA103206C2 UA103206C2 UAA201105290A UAA201105290A UA103206C2 UA 103206 C2 UA103206 C2 UA 103206C2 UA A201105290 A UAA201105290 A UA A201105290A UA A201105290 A UAA201105290 A UA A201105290A UA 103206 C2 UA103206 C2 UA 103206C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compounds
- stem cells
- hematopoietic stem
- expand hematopoietic
- hematopoietic
- Prior art date
Links
- 210000003958 hematopoietic stem cell Anatomy 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 abstract 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 abstract 1
- 238000011316 allogeneic transplantation Methods 0.000 abstract 1
- 230000007123 defense Effects 0.000 abstract 1
- 208000018706 hematopoietic system disease Diseases 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to compounds and compositions for expanding the number of CD34+ cells for transplantation. The invention further relates to a cell population comprising expanded hematopoietic stem cells (HSC) and its use in autologous or allogeneic transplantation for the treatment of patients with inherited immunodeficient and autoimmune diseases and diverse hematopoietic disorders to reconstitute the hematopoietic cell lineages and immune system defense.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10982108P | 2008-10-30 | 2008-10-30 | |
| PCT/US2009/062646 WO2010059401A2 (en) | 2008-10-30 | 2009-10-29 | Compounds that expand hematopoietic stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA103206C2 true UA103206C2 (en) | 2013-09-25 |
Family
ID=52278870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201105290A UA103206C2 (en) | 2008-10-30 | 2009-10-29 | Compounds that expand hematopoietic stem cells |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR122832A2 (en) |
| UA (1) | UA103206C2 (en) |
-
2009
- 2009-10-29 UA UAA201105290A patent/UA103206C2/en unknown
-
2018
- 2018-10-09 AR ARP180102916A patent/AR122832A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR122832A2 (en) | 2022-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO3593B1 (en) | Compounds that expand hematopoietic stem cells | |
| EP2603227A4 (en) | Improved hematopoietic stem and progenitor cell therapy | |
| WO2012012737A3 (en) | Stable tregs and related materials and methods | |
| WO2011139628A8 (en) | Generation of anterior foregut endoderm from pluripotent cells | |
| MX2020005849A (en) | Crispr-cas9 modified cd34+ human hematopoietic stem and progenitor cells and uses thereof. | |
| SG10201808258SA (en) | Improved methods for manufacturing adoptive cell therapies | |
| WO2012102937A3 (en) | Benz imidazole compounds that expand hematopoietic stem cells | |
| PH12013500973A1 (en) | Silent fc variants of anti-cd40 antibodies | |
| GB2526228A (en) | Combined organ and hematopoietic cells for transplantation tolerance of grafts | |
| BR112013002811A8 (en) | simplified basic means for human pluripotent cell culture | |
| JP2016517394A5 (en) | ||
| BR112014005352A2 (en) | eukaryotic organisms and methods for increasing the availability of cytosolic acetyl coa and for producing 1,3-butanediol | |
| EP2558124A4 (en) | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization | |
| CA2866116C (en) | Expansion of alloantigen-reactive regulatory t cells | |
| GB201312433D0 (en) | Enhancement of allogeneic hematopoietic stem cell transplantation | |
| IL276706A (en) | Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants | |
| IN2014DN08964A (en) | ||
| IL290966A (en) | Allogeneic cell compositions and methods of use | |
| UA103206C2 (en) | Compounds that expand hematopoietic stem cells | |
| WO2006102209A3 (en) | Cd34(+) cells and their methods of use | |
| MX347439B (en) | An antibody inducing antigen-specific t cell tolerance and use thereof. | |
| UY32209A (en) | "COMPOUNDS THAT EXPAND HEMATOPOIETIC MOTHER CELLS" | |
| TR201910211T4 (en) | Compounds that increase hematopoietic stem cells. | |
| Konieczna et al. | 35-OR: FACILITATING CELLS DERIVED FROM DECEASED DONOR BONE MARROW AND MOBILIZED PERIPHERAL BLOOD HAVE SIMILAR PHENOTYPIC AND FUNCTION PROPERTIES | |
| Gu et al. | Experimental Study of Human Gingival Tissue-Derived Mesenchymal Stem Cells in Management of Chronic graft-versushost disease (GVHD) |